Kambiz Yazdi
Stock Analyst at BTIG
(2.50)
# 3,052
Out of 5,162 analysts
93
Total ratings
40.6%
Success rate
2.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZVRA Zevra Therapeutics | Maintained: Buy | $24 → $21 | $11.17 | +88.00% | 8 | Nov 19, 2026 | |
| SION Sionna Therapeutics | Maintained: Hold | n/a | $3.73 | - | 10 | Nov 11, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $826 | $284.79 | +190.04% | 18 | Nov 10, 2026 | |
| KZIA Kazia Therapeutics | Reiterated: Buy | $40 | $8.08 | +395.05% | 6 | Oct 21, 2026 | |
| VTVT vTv Therapeutics | Reiterated: Buy | $57 | $24.03 | +137.20% | 10 | Oct 21, 2026 | |
| ABSI Absci | Reiterated: Buy | $16 | $10.48 | +52.67% | 8 | Oct 6, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | $75 | $25.93 | +189.24% | 13 | Oct 1, 2026 | |
| BME: PHM Pharma Mar, S.A. | Initiated Coverage: Buy | €121.00 | €66.85 | +81.00% | 1 | Apr 23, 2026 | |
| ARQT Arcutis Biotherapeutics | Reiterated: Buy | $31 | $34.05 | -8.96% | 6 | Jan 15, 2026 | |
| LQDA Liquidia | Reiterated: Buy | $27 → $31 | $47.38 | n/a | 6 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $7.07 | n/a | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $0.395 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.33 | n/a | 1 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $14 | $1.09 | n/a | 3 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.0005 | n/a | 1 | May 31, 2023 |
Zevra Therapeutics
Nov 19, 2026
Maintained: Buy
Price Target: $24 → $21
Current: $11.17
Upside: +88.00%
Sionna Therapeutics
Nov 11, 2026
Maintained: Hold
Price Target: n/a
Current: $3.73
Upside: -
Praxis Precision Medicines
Nov 10, 2026
Maintained: Buy
Price Target: $826
Current: $284.79
Upside: +190.04%
Kazia Therapeutics
Oct 21, 2026
Reiterated: Buy
Price Target: $40
Current: $8.08
Upside: +395.05%
vTv Therapeutics
Oct 21, 2026
Reiterated: Buy
Price Target: $57
Current: $24.03
Upside: +137.20%
Absci
Oct 6, 2026
Reiterated: Buy
Price Target: $16
Current: $10.48
Upside: +52.67%
Rapport Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $75
Current: $25.93
Upside: +189.24%
Pharma Mar, S.A.
Apr 23, 2026
Initiated Coverage: Buy
Price Target: €121.00
Current: €66.85
Upside: +81.00%
Arcutis Biotherapeutics
Jan 15, 2026
Reiterated: Buy
Price Target: $31
Current: $34.05
Upside: -8.96%
Liquidia
May 28, 2025
Reiterated: Buy
Price Target: $27 → $31
Current: $47.38
Upside: n/a
Mar 25, 2025
Initiated Coverage: Buy
Price Target: $23
Current: $7.07
Upside: n/a
Aug 28, 2024
Reiterated: Buy
Price Target: $15
Current: $0.395
Upside: n/a
Apr 11, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $1.33
Upside: n/a
Mar 7, 2024
Reiterated: Buy
Price Target: $15 → $14
Current: $1.09
Upside: n/a
May 31, 2023
Upgraded: Buy
Price Target: $7
Current: $0.0005
Upside: n/a